CMMB Q1 2018 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

Q1 2018 Earnings

Revenue

Gross Profit

-$12,711

Operating Income

-$3M

Net Income

-$4M

EPS (Diluted)

$-29.54

QoQ Revenue Growth

NaN%

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$12,711	-$11,962	-6.3%
Operating Income	-$3M	-$2M	-66.5%
Net Income	-$4M	-$2M	-54.1%